Literature DB >> 29693655

New activities for old antibiotics.

Jeffrey I Cohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29693655      PMCID： PMC6328309          DOI： 10.1038/s41564-018-0152-4

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN： 2058-5276            Impact factor:   17.745


× No keyword cloud information.
  7 in total

Review 1.  Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.

Authors:  M A Stanley
Journal:  Clin Exp Dermatol       Date:  2002-10       Impact factor: 3.470

Review 2.  Adjuvants for human vaccines.

Authors:  Carl R Alving; Kristina K Peachman; Mangala Rao; Steven G Reed
Journal:  Curr Opin Immunol       Date:  2012-04-19       Impact factor: 7.486

Review 3.  Aminoglycosides: An Overview.

Authors:  Kevin M Krause; Alisa W Serio; Timothy R Kane; Lynn E Connolly
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

4.  High-throughput screening normalized to biological response: application to antiviral drug discovery.

Authors:  Dhara A Patel; Anand C Patel; William C Nolan; Guangming Huang; Arthur G Romero; Nichole Charlton; Eugene Agapov; Yong Zhang; Michael J Holtzman
Journal:  J Biomol Screen       Date:  2013-07-16

Review 5.  Aminoglycoside antibiotics: old drugs and new therapeutic approaches.

Authors:  T Hermann
Journal:  Cell Mol Life Sci       Date:  2007-07       Impact factor: 9.261

6.  High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.

Authors:  Dhara A Patel; Anand C Patel; William C Nolan; Yong Zhang; Michael J Holtzman
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

Review 7.  Discriminating self from non-self in nucleic acid sensing.

Authors:  Martin Schlee; Gunther Hartmann
Journal:  Nat Rev Immunol       Date:  2016-07-25       Impact factor: 53.106
  7 in total
  2 in total

Review 1.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

Review 2.  Interferon-inducer antivirals: Potential candidates to combat COVID-19.

Authors:  Ashkan Bagheri; Seyed Mohammad Iman Moezzi; Pouria Mosaddeghi; Sadra Nadimi Parashkouhi; Seyed Mostafa Fazel Hoseini; Fatemeh Badakhshan; Manica Negahdaripour
Journal:  Int Immunopharmacol       Date:  2020-12-01       Impact factor: 5.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.